Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,928 public trials 460 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Active, Not Recruiting

A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)

NCT06564311

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Cullman, Alabama, United States
  • Center for Neurology and Spine Phoenix, Arizona, United States
  • Perseverance Research Center Scottsdale, Arizona, United States
  • Regina Berkovich MD PhD, Inc West Hollywood, California, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

NCT03500328

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • The University of South Alabama Mobile, Alabama, United States
  • St. Joseph's Hospital & Medical Center - Barrow Neurological Institute Phoenix, Arizona, United States
  • CommonSpirit Health Research Institute Carmichael, California, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

MSCopilot Users' Feedback in Real Life - Outcomes Regarding Integration in Patients' pathWay and Users' ExpeRience

NCT06922942

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Jenny Feng New Orleans, Louisiana, United States
  • Robert Naismith St Louis, Missouri, United States
  • Gabriel Pardo Oklahoma City, Oklahoma, United States
  • Leorah Freeman Austin, Texas, United States
View Trial Details
Active, Not Recruiting

Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis

NCT04495556

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Active, Not Recruiting

Biobank For MS And Other Demyelinating Diseases

NCT00445367

Conditions
Acute Disseminated Encephalomyelitis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +32 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Stanford University Stanford, California, United States
  • The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver Aurora, Colorado, United States
  • Shepherd Center Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis

NCT04879628

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Center for Neurology and Spine- Site Number : 8400007 Phoenix, Arizona, United States
  • University of South Florida Site Number : 8400001 Tampa, Florida, United States
  • The Neurological Institute Site Number : 8400004 Charlotte, North Carolina, United States
  • Medical College of Wisconsin- Site Number : 8400006 Milwaukee, Wisconsin, United States
View all 37 locations
View Trial Details

Related conditions